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Apheresis in the ABMT Outpatient Setting
Susan Drago. Duke University Hospital, Durham, NC
Purpose: To describe strategies for successful implementa-
tion and positive outcomes of a comprehensive outpatient
Adult Blood and Marrow Transplant (ABMT) Apheresis
Program
Bone Marrow Transplant (BMT) nurses are trained
experts in the care of patients along the continuum including
pre-transplant, peri-transplant and post-transplant periods.
Leukapheresis for the collection of peripheral blood
progenitor cells (PBPC), donor lymphocytes, granulocytes,
and Extracorporeal Photopheresis (ECP) can be successfully
incorporated into the scope of practice of the BMToutpatient
nurse. With the opening of the Duke Adult Blood and
Marrow Transplant (ABMT) Clinic in 1992, all nurses were
trained in apheresis and were required to perform leuka-
pheresis for the collection of PBPC. This consisted of a staff of
5 registered nurses. The initial model allowed for ﬂexibility
in stafﬁng to accommodate a changing patient census and
acuity in the clinic and apheresis.
Our apheresis program has experienced a 50 % growth in
the past 10 years. With this growth we have added two new
apheresis devices which added another level of complexity
to the scope of practice. As our program and staff grew, and
as regulations regarding safe practice have evolved, we found
it increasingly challenging to maintain apheresis compe-
tency for our larger staff, and still provide high quality care in
the outpatient setting. Therefore, in 2010, we implemented
an optional Core Apheresis Team model, to which nurses
may voluntarily commit to being a member.
To maintain apheresis competency of a core group of
nurses, a regular rotation assignment was implemented and
an apheresis coordinator was designated. Advantages of this
model include: 1) improved competency validation 2)
decrease in procedural errors 75% and associated costs in the
ﬁrst month 3) consistency in apheresis practice 4) increased
nursing satisfaction by allowing nurses to opt whether they
become a member of the core team. Apheresis has long been
an outpatient procedure. As we move more care into the
outpatient setting, our coordination of apheresis practice
provides a model to follow for implementation of other
services we provide to our ABMT patients.487
Managing of Daily Improvement (MDI) Through
Daily Huddles: Creating Culture and Engaged Problem
Solving Nurse Coordinator Staff at City of Hope
Department of Hematology & Hematopoietic Cell
Transplant (HEM/HCT)
Gerardo Gorospe 1, Shirley Johnson 1, Kimberly Carli 2,
Amin Rabiei 2. 1 City of Hope National Medical Center,
Duarte, CA; 2 Accelerating City of Hope Excellence, City of Hope,
Duarte, CA
Background: Transplant nurse coordinators at City of Hope
work daily to manage patient schedules, collaborate care
coordination, provide patient education and achieve patient
expectations through complexities of daily challenges.
Employees create “work-arounds” instead of solving prob-
lems. As any work place, problems in the daily work are
opportunities for improvement. At COH, there has not been
a standard problem solving methodology. In many cases,improvements are implemented but are not consistently
sustained. Not all staff members participate in project
improvement projects. Solved problems, or “work-arounds,”
are not documented and tracked. COH recognized the need
to create a culture of continuous improvement. COH needed
to advance to daily problem solving and information sharing
activities in the HEM/HCT department and as well as
throughout COH Medical Center.
Purpose: To create a process of daily problem solving and
information sharing activities. The staff is fully engagedwith;
ﬁnding, prioritizing, assigning, and solving problems in
progress until completion. To develop a place for staff to
share information and to promote diversity & inclusion by
encouraging all team members to share ideas with each
other.
Intervention: A pilot of Managing Daily Improvement
(MDI) through daily huddles at the “huddle central” board
was implemented in the department. Through the
Accelerating City of Hope Excellence (ACE) team, manage-
ment and key personnel were given education on an MDI
tool: “huddle central.” Standard work on conducting the
huddle was created. Management and key personnel then
educated staff on standard work which includes ﬁlling out
“Improvement Opportunity” cards to identify challenges the
staff have.
Discussion: Through the ACE initiative, several key areas
were selected to pilot MDI. HEM/HCT Nurse Coordinator area
was one of ﬁrst 4 areas selected. The focus is on practical
problem solving to improve communication and promote
a culture of continuous improvement. It establishes a daily
discipline of ﬁnding, prioritizing, assigning, and solving
problems until completion. Staff are encouraged and
empowered to solve problems in teams. It is a place for staff
to share key information about their daily work with each
other. The huddle metric targets were: 1) solved 4 problems
per month; 2) are held 90% of the time; and 3) 75% of staff
attends daily. Since May, the problems solved per month
averaged 6.75; huddles held per month averaged 95%; and
staff daily attendance averaged 68%. Some examples of
solutions were: improvement of pre-transplant class patient
attendance; improvement of communication and dissemi-
nating information to other department; and improving
timely turnaround of physician orders for signature. We will
continue to monitor the metrics established, improve the
daily huddle attendance and number of problems solved.488
Establishing a Shared Governance, Unit Based Council for
the Hematology/Hematopoietic Cell Transplantation
(Hem/HCT) Nurse Coordinator (NC) and Clinical Trial
Nurse (CTN)
Donna Hawkins, Kathryn Irenze, Emily Krupka,
Kiausha Logan, Kathryn Patané, Bernadette Pulone,
Gerardo Gorospe, Naomi Jones. City of Hope National Medical
Center, Duarte, CA
Background: The role of the NC/CTN is an intricate and
integral part of the patient care experience. The NC/CTN
provides extensive patient education, advocacy, coordinates
diagnostic testing, clinical trial participation and follow-up
care in collaborationwith amultidisciplinary team; however,
current workﬂow processes for the NC/CTN role are not
clearly deﬁned. We established shared governance via Unit
Based Council (UBC) to provide structure and context to
organize deliverable goals.
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role, in line with Hem/HCT department and nursing leader-
ship goals. Improve patient outcomes through evidence
based practice and collaborationwith multidisciplinary team
throughout the decision making process. Maintain autono-
mous professional nursing role while providing empower-
ment and role satisfaction.
Intervention: Shared governance education was provided
to staff followed by an electronic survey to gauge interest in
creating and participating in a unit based council. A subset
of volunteers was selected to serve on the newly created
UBC. Through an evidence based approach, a charter
was established. Members serve as representatives of our
NC/CTN staff within which members rotate leadership
positions.
Evaluation/Discussion: Once the charter was developed and
approved, per quorum, work commenced on the initiatives:
1) Ownership of ‘the patient and family transplant education
class’ was returned to the NC staff. This opportunity for
change resulted from an issue identiﬁed in a “management
of daily improvement” (MDI) huddle. 2) The material taught
was reviewed and updated to current practice, utilizing input
from a non-UBC sub-committee. To date, we have seen an
overall increase in attendance and have established
measurable units. It is too early to determine degree of
success, however this initiative will help better serve our
patients, improve outcomes and allow us to address future
concerns with measurable targets. 3) A staff satisfaction
survey was developed, implemented, analyzed and pre-
sented. Ideas to improve overall satisfaction are currently
underway. 4) Creation of a standard orientation work ﬂow
process, role speciﬁc checklists and central orientation
binder for reference of the deﬁned standards, is work in
progress. Each group in the NC/CTN ofﬁce has their own
orientation model without a universal process between
groups. To address this need, a structured framework was
applied to the existing process in attempt to streamline the
comprehensive orientation process and centralize references
for new employees joining the group.
Future and on-going projects include: 1) Standardize
documentation; 2) Collect professional articles that repre-
sent current ‘best’ evidence based practices for imple-
mentation; 3) Create reward and recognition programwithin
NC/CTN group; and 4) Update annual review evaluation
forms.489
2012 BMT ICU Utilization Project Update
Trisha Jenkins. BMT Nursing, Stanford Hospital, Stanford, CA
Signiﬁcance & Background: Resource utilization in health-
care continues to be a top priority. The rising cost of
healthcare and limited resources, including ICU beds, makes
appropriate utilization of the ICU a critical issue.10 years ago,
our BMT Program developed and began utilizing ICU
admission criteria. We have monitored ICU utilization by
collecting data on whether patients met criteria for ICU
admission, the reason for transfer, the length stay and
outcomes. Historically, BMT patients are high acuity and now
older patients with co-morbidities are candidates for trans-
plant. Appropriate ICU utilization is an important goal of our
program.
Purpose: The 10 years of data allows us to evaluate proba-
bilities of survival following ICU with the goal of appropriate
ICU utilization.Interventions: We have developed and continue to revise
ICU admission criteria based on ongoing review of the ICU
data. An understanding of outcomes following ICU is used by
the medical team to counsel patients and families facilitating
informed decisions about their care. To improve the care of
patients in the ICU, the BMT and ICU teams round together
daily including a discussion of goals of care and family
meetings every 2-3 days.
Evaluation: Ongoing evaluation determines if ICU admission
criteria was met, reasons for transfer, length of stay and
outcomes. Most of the patients transferred to the ICU meet
our established criteria. We have noted trends for patients
transferred to the ICU more than once have very poor
outcomes. Additionally, the length of ICU stay predicts for
poor outcomes.
Discussion: Ongoing evaluation of our ICU utilization data
and reviews of the literature provide the BMT team with
information that can be used to counsel patients and families
on the probabilities of survival. This information allows for
patients and families to make informed choices regarding
their care and facilitates appropriate ICU utilization.490
Implementing Novel Predictive Parameters in Apheresis
Bethany King 1, Joshua Geary 2, Donna Crown 3,
Olive Sturtevant 1, Sharon Anderson 2, Karl Stasko 2,
Amy Emmert 4, C John Luckey 3. 1 Cell Therapy Quality
Assurance, Dana Farber Cancer Institute, Boston, MA; 2 Cell
Manipulation Core Facility, Dana Farber Cancer Institute;
3 Kraft Family Blood Donor Center, Brigham and Women's
Hospital; 4 Dana-Farber Cancer Institute, Boston, MA
Background: Reducing the time a patient is present in the
apheresis facility for autologous collection can help trans-
plant centers better utilize staff. Waiting for CD34+ cell count
results can delay start of apheresis for an hour or more. An
alternative test for prediction of stem cell mobilization using
HPC count to provide a quickly resulted (<5 minutes) proxy
for CD34+ results was explored. The HPC parameter is
measured using the Sysmex XE analyzer and is a less mature
cell with a 0.7 correlation with CD34+ cell count. We
implemented this test in combination with CD34+ testing to
identify patients who could start apheresis without waiting
for the CD34+ results. The goal was to reduce patient wait
time and deliver the product to the processing lab earlier,
with better utilization of technicians.
Methods: Using previously collected data, our center
decided to collect immediately any autologous patient not
mobilized with AMD who had an HPC value of over 30. The
cutoff was set high to minimize false positives, patients who
were run who ultimately had low counts. Based on the
guideline we established, we allocated patients to two
subsets: move to apheresis without waiting for CD34+
results or hold for CD34+ results. Patients who were held
pending CD34+ results were subsequently assessed accord-
ing to Institute standards. We collected baseline and post-
implementation data to assess howmuch time patients were
spending in apheresis and the time that elapsed before
delivery to the processing lab pre- and post-implementation.
Results: Of the eligible patients, 62% could begin apheresis
upon HPC resulting and 38% were categorized as needing to
wait for CD34+ results. In the ﬁrst 3 months post-imple-
mentation, patients who initiated collection based on the
HPC parameter were found to begin collecting 40 minutes
earlier than historic averages, and over an hour earlier than
